Search

Your search keyword '"Oren, D. A."' showing total 388 results

Search Constraints

Start Over You searched for: Author "Oren, D. A." Remove constraint Author: "Oren, D. A."
388 results on '"Oren, D. A."'

Search Results

1. Correlation Between the Subtype of Anti-HLA Donor Specific Antibodies and Rejection Assessed by Molecular Microscope

2. History of Malignancy and Rejection Outcomes Assessed by Molecular Microscope (MMDx)

3. Consistent Sublingual Microvascular Health Among Heart Transplant Recipients Regardless of Coronary Allograft Vasculopathy Status

4. Sublingual Microcirculation in Acute Mechanical Circulatory Support in Cardiogenic Shock

5. Implications of ABO Unmatched Donors on Cardiac Allograft Rejection Assessed by the Molecular Microscope (MMDx)

6. Molecular Microscope Findings in Low-Grade Histological Rejection: A Less Benign Reality Than Assumed

7. Racial and Ethnic Disparities in De-Novo Donor Specific Antibodies (DSA) and Rejection Rates in Heart Transplant Recipients Assessed by Molecular Microscope

8. Sex Differences in Allograft Rejection After Heart Transplantation (HT). Molecular Microscope (MMDx) Results

9. Microcirculatory Dysfunction in Cardiogenic Shock

10. Molecular Microscope (MMDx) Results in the Sensitized Heart Transplant Recipient

11. Association of Sex Mismatch with Allograft Rejection After Heart Transplantation (HT) - Molecular Microscope (MMDx) Results

12. Clinical Utility of Molecular Microscope Diagnostic System (MMDx) in Heart Transplant Recipients: Moving Towards a New Paradigm

13. Inflammatory Cardiomyopathies are Associated with Higher Rates of T-Cell Mediated Rejection. Molecular Microscope Results

14. Impact of MTOR Inhibitors on Heart Allograft Rejection Using Tissue-Based Gene-Expression Profiling. Molecular Microscope (MMDx) Results

15. Impact of Race Mismatch in Allograft Rejection After Heart Transplantation. Molecular Microscope (MMDx) Results

16. Does Multiorgan Transplantation Correlate with Reduced Rates of Rejection as Evaluated by the Molecular Microscope (MMDx)?

17. Impact and Outcomes of Induction Therapy on Donor-Derived Cell-Free DNA Levels and Peripheral Gene-Expression Profiling in Heart Transplant Recipients

18. LVAD Bridge to Transplant and Rejection Assessed by Molecular Microscope

19. Impact of Epstein-Barr Virus (EBV) Mismatch on Gene-Expression Profiling (MMDx) and Rejection

20. Efficacy of Letermovir for CMV Prophylaxis in Heart Transplant Recipients with Moderate to High Risk CMV Serostatus

21. Molecular Microscope (MMDx) After COVID-19 Vaccination in Heart Transplant Recipients

22. Effects of Belatacept Therapy on Gene Expression Profiling and Rejection in Heart Transplant Recipients: A Molecular Microscope (MMDx) Evaluation

23. Correlation Between Peripheral Gene-Expression Profiling (GEP-Allomap) and Tissue Gene-Expression in T-Cell Mediated Rejection Detection

24. Correlation Between Donor-Specific Antibodies and Molecular Microscope Results in Heart Transplant Recipients

25. Is There A Correlation Between a High Immuknow Level and Increased Rates of Rejection? Insights from Molecular Microscope (MMDx)

26. What is Behind the Quilty Effect? Molecular Microscope Insights

27. Clinical Implications of Borderline Rejection Assessed by Molecular Microscope

28. Comparison of Microcirculatory Function in Patients with HeartMate 3 LVAD and Healthy Controls

29. Impact of MIC-A Antibodies on Antibody Mediated Rejection (ABMR). Molecular Microscope Results (MMDx)

30. Correlation Between Donor-Derived Cell-Free DNA (dd-cfDNA) and Molecular Microscope (MMDx) in Heart Transplant Recipients

31. Impact of Cytomegalovirus (CMV) Mismatch on Rejection Assessed by Molecular Microscope (MMDx)

32. Microvascular Responses to Donor Specific HLA Antibodies in Heart Transplantation. Sidestream Dark Field Imaging Results

33. Impact and Outcomes of Hepatitis C Viremic Donors (HCV-NAAT) on Donor-Derived Cell-Free DNA Levels and Gene-Expresion Profiling (GEP-Allomap) in Heart Transplant Recipients

34. Diminished Microvascular Health in Heart Transplant Recipients Relative to Healthy Controls

35. Microcirculatory Dysfunction Across SCAI Stages of Cardiogenic Shock

38. (280) Comparison of Two Commercially Available Donor-Derived Cell-Free DNA Assays for Surveillance of Rejection in Heart Transplant Recipients

39. (230) The Effect of Preservation Modality on Myocardial Injury - A Single Blinded Study

40. (793) Validation of the Heartmate 3 Survival Risk Score in a Large Left Ventricular Assist Device Center

41. (1029) Donor-Derived Cell-Free DNA in Heart Transplant Recipients with a History of Congenital Heart Disease

42. (494) The Utility and Characteristics of Cardiovascular Magnetic Resonance Imaging in Suspected Chronic Allograft Rejection

46. Trans-catheter edge-to-edge mitral valve repair in patients with acute decompensated heart failure due to severe mitral regurgitation – a single centre experience

48. Long-Term Outcomes for Pediatric HT Patients Transitioning to Adult Care

49. New-Onset Diabetes in Patients Post-Heart Transplantation; the Role of Hypertension and Novel Diabetic Medications

50. Psychiatric Comorbidities in Pediatric HT Patients Transitioning to Adult Care

Catalog

Books, media, physical & digital resources